Recently, it has shown superior survival compared with BBB‐penetrating chemotherapy in lymphoma patients with CNS involvement, indicating the promising potencies of BTK inhibitors to treat CNS lymphoma.16 The gene discussed is BTK; the disease is lymphoma.